12,841 resources
Start Prev Rows 8800 - 9000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation | active | 2024-08 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.45 | ACE inhibitor allergy RXNORM | active | 2024-12 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT | active | 2024-07 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.35 | Pressure Ulcer Stage | active | 2023-07 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1037 | Risk Category | active | 2008-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) | active | 2020-01 | sct tho | |||
hl7.fhir.us.vrdr | R4 | vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet | active | pher | 2024-10 | hl7 | sct tho | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.977 | Contact Role | active | 2008-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.113883.3.88.12.3221.8.7 | Medication Route FDA Value Set | active | 2014-01 | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7694 | Administration Route (RIBD) | active | 2018-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3132 | Lab Result (Rubella) | active | 2008-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3127 | Genotype (Rubella) | active | 2017-01 | sct tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.320 | Opioids ATCPROD N02A | active | 2024-09 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.473 | Tetanus toxoid, diphtheria (Td) Vaccine | active | 2023-07 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.569 | Allergen Immunotherapy | active | 2023-08 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.976 | Ensifentrine | active | 2025-01 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.977 | Dupilumab | active | 2025-01 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.106 | Cytochrome P450 2C9 inhibitors | active | 2023-10 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.478 | Allergy to HPV Vaccine | active | 2023-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.570 | Allergy to house dust mites SCT | active | 2023-08 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.618 | relatedconditions_Asthma SCT | active | 2023-09 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | BodyTempAssociatedSituationVS | Body Temperature Associated Situation value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | BodyWeightAssociatedSituationVS | Associated Situation value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | bodyTempMeasurementDeviceVS | Body Temperature Measurement Device value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | exertionPhaseVS | Exertion Phase value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.cardx-htn | R4 | exertionPhaseVS | Exertion Phase value set | draft | 2023-08 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | MeasSettingVS | Measurement Setting value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.cardx-htn | R4 | MeasSettingVS | Measurement Setting value set | draft | 2023-08 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | sleepStatusVS | Sleep Status value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.cardx-htn | R4 | sleepStatusVS | Sleep Status value set | draft | 2023-08 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | weightMeasurementDeviceVS | Weight Measurement Device value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | bpMeasMethodVS | Blood Pressure Measurement Method value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.cardx-htn | R4 | bpMeasMethodVS | Blood Pressure Measurement Method value set | draft | 2023-08 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | heartRateMeasMethodVS | Heart Rate Measurement Method value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.cardx-htn | R4 | heartRateMeasMethodVS | Heart Rate Measurement Method value set | draft | 2023-08 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | heightLengthMeasMethodVS | Height Length Measurement Method value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | respiratoryRateMeasMethodVS | Respiratory Rate Measurement Method value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | respiratoryRateMeasDeviceVS | Respiratory Rate Measurement Device value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | heightLengthMeasDeviceVS | Height Length Measurement Device value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | heartRateMeasDeviceVS | Heart Rate Measurement Device value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.cardx-htn | R4 | heartRateMeasDeviceVS | Heart Rate Measurement Device value set | draft | 2023-08 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | bpMeasDeviceVS | Blood Pressure Measurement Device value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | sensorDescriptionVS | Sensor Description value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.cardx-htn | R4 | bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set | draft | 2023-08 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | heightBodyPositionVS | Height Body Position value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | bpCuffSizeVS | Blood Pressure Cuff Size value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set | draft | 2024-10 | hl7 | fhir sct | ||
hl7.fhir.us.cardx-htn | R4 | heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set | draft | 2023-08 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | bodyTempMeasBodyLocationPrecoordVS | Body Temperature Measurement Body Location value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | bodyPositionVS | Body Position value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.cardx-htn | R4 | bodyPositionVS | Body Position value set | draft | 2023-08 | hl7 | sct | ||
hl7.fhir.us.vitalsigns | R4 | bodyWeightMeasurementAssociatedPrecondVS | Body Weight Measurement Associated Precondition value set | draft | 2019-05 | hl7 | sct | ||
hl7.fhir.us.vitalsigns | R4 | bpMeasDeviceCSVS | Blood Pressure Measurement Device and Cuff Size value set | draft | 2019-05 | hl7 | fhir sct | ||
hl7.fhir.us.vitalsigns | R4 | clothingWornDuringMeasureVS | Clothing Worn During Measure value set | draft | 2019-09 | hl7 | fhir sct | ||
hl7.fhir.us.vitalsigns | R4 | bodyTempMeasMethodDeviceVS | Body Temperature Measurement Method Device value set | draft | 2019-05 | hl7 | fhir sct | ||
hl7.fhir.us.vitals | R4 | WeightUOMVS | Weight Units of Measure value set | draft | 2024-10 | hl7 | ucum | ||
hl7.fhir.us.vitals | R4 | TemperatureUOMVS | Temperature Units of Measure value set | draft | 2024-10 | hl7 | ucum | ||
hl7.fhir.us.vitals | R4 | LengthUOMVS | Length Units of Measure value set | draft | 2024-10 | hl7 | ucum | ||
fhir.tx.support.r4 | R4 | snomed-intl-ips | SNOMED CT® International Patient Set (IPS) | active | 2022-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.80.28 | Procedure | active | 2024-06 | hl7 | sct | ||
hl7.fhir.us.qicore | R4 | qicore-observation-body-position | QICore Observation Body Position | active | cqi | 2018-08 | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | PriorMyocardialInfarction | Prior Myocardial Infarction | active | cic | 2023-11 | hl7 | sct | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.516 | Allergy to Herpes Zoster Vaccine SCT | active | 2023-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.25 | Attention Deficit and Hyperactivity Disorder | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.22 | Acute Kidney Injury | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.38 | Coronary Artery Disease | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.39 | Chronic Kidney Disease | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.40 | Chronic Obstructive Pulmonary Disease | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.33 | Failure to Thrive | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.31 | Parkinson's Disease and Parkinsonism | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.23 | Anemia | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.24 | Cardiac Arrhythmias | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.26 | Cerebrovascular Disease | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.41 | Diabetes Mellitus | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.36 | Dyslipidemia | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.37 | Heart Failure | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.12 | Hypertension | active | 2022-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.35 | Mood Disorders | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.34 | Osteoporosis | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.28 | Proteinuria | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.27 | Seizure Disorder | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.30 | Thromboembolic Disease | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.29 | Thyroid Hormone Disorder | active | 2023-10 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1251.32 | Upper GI Diseases | active | 2023-10 | hl7 | sct | ||
hl7.fhir.us.registry-protocols | R4 | CardiacCatheter | SNOMED Cardiac Catheters | active | cic | 2023-11 | hl7 | sct | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1237.12 | SNOMEDFindingValuesQualifierValue | active | 2024-01 | hl7 | sct | ||
hl7.fhir.us.registry-protocols | R4 | PackedRedBloodCells | Packed Red Blood Ceels | active | cic | 2023-11 | hl7 | sct | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.178 | Intubation | active | 2023-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.180 | Tracheostomy Procedures | active | 2024-01 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.182 | Head and Neck Surgeries with High Risk Airway Compromise | active | 2025-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.85 | Elective Inpatient Encounter | active | 2023-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.240 | Degenerative Neurological Disorder | active | 2024-01 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.238 | Neuromuscular Disorder | active | 2023-09 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1092 | Hemorrhagic Illness Syndrome (BT) | active | 2008-01 | fhir | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1093 | Localized Cutaneous Lesion Syndrome (BT) | active | 2008-01 | fhir | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7735 | SPN/IPD Serotype (RIBD) | active | 2018-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7934 | Microorganism (STD) | active | 2020-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3056 | STORET Chemicals (EPA) | active | 2008-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7712 | School Year (RIBD) | active | 2018-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7864 | Specimen Source (C. auris) | active | 2019-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7637 | Seafood Preparation (FDD) | active | 2018-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7638 | Seafood Source (FDD) | active | 2017-01 | tho oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.181 | Coccidioidomycosis (Disorders) (SNOMED) | active | 2024-01 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.20.22 | HPDocumentType | active | 2025-04 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.31 | ConsultDocumentType | active | 2025-03 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.4.1 | DischargeSummaryDocumentTypeCode | active | 2024-06 | hl7 | loinc | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) | active | 2016-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7332 | Setting of Further Spread | active | 2015-01 | sct tho oid | |||
hl7.fhir.us.spl | R5 | splSectionCodes | SPL Section Codes | trial-use | 1 | brr | 2025-07 | hl7 | loinc |
fhir.acme.affiliate-report | R4 | section-type-vs | Section Type ValueSet | draft | 2025-05 | hl7 | internal | ||
hl7.fhir.us.ndh | R4 | NdhSecureExchangeArtifactsVS | Secure Exchange Artifacts Value Set | trial-use | pa | 2025-07 | hl7 | fhir | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.29 | DIRQuantityMeasurementTypeCodes | active | 2024-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | periwoundConditionVS | ReriwoundConditionvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundBedAppearanceVS | WoundBedAppearanceValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundAssessmentInterpretationVS | WoundAssessmentInterpretationvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundTypeEtiologyVS | WoundTypeEtiologyvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundGradationVS | WoundGradationValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | definedLimitsVS | Defined Limits value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | clockFacePositionVS | ClockFacePositionValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundExudateOdorVS | WoundExudateOdorValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | presentAbsentVS | PresentAbsentValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | episodeVS | Episodevalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | trendVS | Trendvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundInternalItemOrBodyStructureVisibleVS | WoundInternalItemOrBodyStructureVisiblevalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundEdgeDescriptionVS | WoundEdgeDescriptionValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundExudateColorVS | WoundExudateColorValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundExudateAppearanceVS | WoundExudateAppearanceValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundMeasurementDeviceVS | WoundMeasurementDeviceValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundBedColorVS | Wound Bed Color value set | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundEdgeColorVS | WoundEdgeColorValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundShapeVS | Wound Shape value set | draft | 2019-09 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundExudateAmountDescriptionVS | WoundExudateAmountDescriptionValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.vitals | R4 | sPO2BodyLocationVS | Oxygen Saturation Body Location value set | draft | 2024-10 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | courseVS | Coursevalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | bodyLocationQualifierVS | BodyLocationQualifiervalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundTypeVS | CIMIWoundTypevalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | bodyLocationOrientationVS | BodyLocationOrientationvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | underlyingAnatomicalStructureVS | UnderlyingAnatomicalStructurevalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | pressureUlcerAssociationVS | PressureUlcerAssociationvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | bodySideVS | BodySidevalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | qualitativeWoundDepthVS | QualitativeWoundDepthvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | woundAnatomicLocationVS | WoundAnatomicLocationvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | yesNoVS | YesNoValueSet | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | surfaceOrientationVS | SurfaceOrientationvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | bodyLandmarkDescriptionVS | BodyLandmarkDescriptionvalueset | draft | 2019-06 | hl7 | sct | ||
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | recurrenceVS | Recurrencevalueset | draft | 2019-06 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7959 | Underlying Condition(s) (Leptospirosis) | active | 2020-01 | sct tho | |||
signal.core.r4 | R4 | questionnaire-ccars-sexual-orientation | Questionnaire CCARS Sexual Orientation | draft | 1 | pa | hl7 | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1103 | Semantic Clinical Drug (Ingredient plus strength and dose form) | active | 2020-01 | rx | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1104 | Semantic Clinical Drug Form (Ingredient plus dose form) | active | 2020-01 | rx | |||
hl7.fhir.us.davinci-drug-formulary | R4 | SemanticDrugFormGroupVS | Semantic Drug Form Group Codes | trial-use | phx | 2025-02 | hl7 | rx | |
hl7.fhir.us.davinci-drug-formulary | R4 | NonPackSemanticDrugVS | Non-Pack Semantic Drug Codes | trial-use | phx | 2025-02 | hl7 | rx | |
hl7.fhir.us.davinci-drug-formulary | R4 | SemanticDrugVS | Semantic Drug Codes | trial-use | phx | 2025-02 | hl7 | fhir rx | |
hl7.fhir.us.military-service | R4 | military-service-separation-reason-vs | Separation Reason Value Set | active | 2023-05 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1290.5 | Septic Shock | active | 2025-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1290.6 | Septic Shock | active | 2025-04 | hl7 | icd | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7706 | Sequelae (RIBD) | active | 2018-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7773 | Serogroup Method (RIBD) | active | 2018-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7736 | Serotype Method (RIBD) | active | 2018-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) | active | 2010-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7477 | Positive Negative 4 Fold Rise Not Done | active | 2016-01 | sct oid | |||
fhir.nigeriaImmunization | R4 | neir-service-request-vs | NGTSSVSRQTS | active | 2025-05 | hl7 | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3227 | Location performing blood or body fluid exposure procedure | active | 2009-01 | tho | |||
hl7.fhir.us.breast-radiology | R4 | ServiceRecommendationsVS | ServiceRecommendations ValueSet | active | 2022-12 | hl7 | fhir | ||
hl7.fhir.us.ecr | R4 | valueset-ersd-endpoint-connection-type | eRSD Endpoint Connection Type Codes | active | 2020-08 | hl7 | fhir tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1077 | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.304 | Pesticide Related Illness (Disorders) (SNOMED) | active | 2023-01 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7807 | Bird Exposure Setting (RIBD) | active | 2018-01 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7634 | Sexual Contact (FDD) | active | 2017-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3231 | Disease Type (STD) | active | 2009-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7639 | Shellfish Distributed (FDD) | active | 2017-01 | tho oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.619 | b.well Herpes Zoster Vaccine CN_HD_SNOMED | active | 2025-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.561 | Oral Steroid for Cluster Headache | active | 2023-12 | hl7 | rx | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) | active | 2020-01 | sct tho | |||
fhir.cdc.opioid-cds-r4 | R4 | sickle-cell-diseases | Sickle-cell diseases | active | 2023-05 | hl7 | sct icd | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7771 | Side Effect Time to Onset (TB) | active | 2017-12 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) | active | 2018-01 | sct tho oid | |||
signal.core.r4 | R4 | signal-organization-license | Signal Organization License | draft | 2023-07 | hl7 | |||
signal.core.r4 | R4 | signal-organization-qualification | Signal Organization Qualification | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | signal-healthcare-service-type | Signal Healthcare Service Type | draft | 1 | pa | hl7 | ||
signal.core.r4 | R4 | signal-region | Signal Region | draft | hl7 | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) | active | 2018-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) | active | 2015-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) | active | 2017-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3240 | Flu Signs and Symptoms | active | 2009-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7460 | Signs Symptoms (Arbovirus) | active | 2016-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7482 | Signs Symptoms (Chikungunya) | active | 2016-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7481 | Signs Symptoms (Dengue) | active | 2016-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7459 | Signs Symptoms (Zika) | active | 2016-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) | active | 2020-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) | active | 2018-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) | active | 2018-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) | active | 2021-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8059 | Signs and Symptoms (Hepatitis) | active | 2021-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) | active | 2018-01 | sct tho | |||
hl7.fhir.us.directory-query | R4 | NetworkTypeVS | Network Type Value Set | active | 2022-12 | hl7 | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | NetworkTypeVS | Network Type VS | trial-use | fm | 2025-02 | hl7 | fhir | |
hl7.fhir.us.ndh | R4 | NetworkTypeVS | Network Type Value Set | trial-use | pa | 2025-07 | hl7 | tho |